News

Nov 13 2023

Tevard Biosciences appoints Dr. Gregory Robinson as Chief Scientific Officer

Read more
Feb 28 2023

Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy

Read more